 |
HuH-7 Transfection Reagent |
|
|
Catalog # 1775 - 0.5 mL $ 125.00
Catalog # 1776 - 1.5 mL $ 283.00
Transfection reagent for HuH-7 cells
- Optimized easy-to-use transfection protocol included for transfection of DNA, mRNA, siRNA and microRNA
- Transfection Enhancer reagent included
- Works with/without serum
- Compatible with transfection in any plate format
- Tested for absence of microbial contamination
- Suitable for DNA/siRNA cotransfection experiments
- Developed and manufactured by Altogen Biosystems
Transfection Efficiency:
Reagent exhibits at least 60% transfection
efficiency of siRNA delivery. Transfection efficiency
was determined by Fluorescent microscopy.
Transfection Protocol:
Transfection protocols are provided with
the purchase of the reagent.
|
 |
HUH-7 cell line |
|
HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. Human hepatoma cells is an immortal cell line of epithelial like tumorigenic cells that usually grows in 2D monolayers. Human hepatoma cells (HuH-7) was found to replicate continuously in a chemically defined medium. The cells grew better than in serum containing medium without any period of adaptation.
 |
Altogen Biosystems |
|
Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of cell type specific transfection reagents. Efficient delivery of DNA and RNA molecules (siRNA, plasmid DNA, mRNA, microRNA) enabled by advanced formulation of reagents and peculiar design of transfection protocols. Altogen Biosystems offers a complete transfection system for a broad range of cell lines and primary cells. Reagents are functionally tested to be reproducible, serum compatible, induce low toxicity, and can be used for co-transfection experiments, and high throughput applications.
 |
Transfection Resource |
|
siRNA Transfection || Transfection Methods || Stable Transfection || RNAi || siRNA Library Screening || RNAi Therapeutics || Cell Transfection || In Vivo Transfection Reagents || Cell Line Specific Transfection Reagents
 |
Featured Products |
|
In Vivo Transfection Reagents || Fibroblast Cells Transfection Reagent || Astrocyte Cells Transfection Reagent || HEK-293 Transfection Reagent || MEF Transfection Reagent || HepG2 Transfection Reagent || CHO Reagent || MDA-MB Transfection Reagent || Cos7 Transfection Reagent || A549 Transfection Reagent || NIH3T3 Reagent || HUVEC Transfection Reagent || LNCaP Transfection Reagent || MCF-7 Reagent || PC-12 Reagent
 |
Altogen Research Services |
|
Altogen Custom Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.
|